title: Pioglitazone and bladder cancer: FDA's assessment.
authors.affiliation: Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Christian
authors.initials: C
authors.lastname: Hampp
authors.affiliation: Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Pippins
mesh_terms: D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077205:Pioglitazone / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology*
chemical_list: D007004:Hypoglycemic Agents; D000077205:Pioglitazone